Positive list system may solve cumulative NHI financial problems.

Published: 2006-12-11 06:57:00

Updated: 2006-12-11 06:57:00

Chief administrator Kim Chang-yeop of the Health Insurance Review Agency (HIRA) said that ever rising trend of the NHI medication expenditures should be curbed in one way or the other under the drug pricing optimizing plan (positive list system) by all means. He indicated that the drug price shou...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK